Financial News

Recent Quotes

My Watchlist

Indicators

Overview

Week In Review: Arrivent BioPharma Raises $175 Million In IPO For In-Licensings From China

By: TalkMarkets

January 27, 2024 at 13:40 PM EST

ArriVent BioPharma priced its upsized Nasdaq IPO at $18 dollars per share, raising $175 million. The company’s stated goal is to find promising novel assets from China and other countries, which it aims to bring to the US market.

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Financial News

Week In Review: Arrivent BioPharma Raises $175 Million In IPO For In-Licensings From China

Popular Pages